{"paper_id": "0a6fdb6dce5a1277b1e23a6811b9eaa69866bb50", "metadata": {"title": "", "authors": [{"first": "Vaibhav", "middle": [], "last": "Bagaria", "suffix": "", "affiliation": {"laboratory": "", "institution": "N Reliance Foundation Hospital", "location": {"addrLine": "Sir H", "settlement": "Girgaum, Mumbai", "region": "Maharashtra", "country": "India"}}, "email": "bagariavaibhav@gmail.com"}, {"first": "Raju", "middle": [], "last": "Vaishya", "suffix": "", "affiliation": {"laboratory": "", "institution": "N Reliance Foundation Hospital", "location": {"addrLine": "Sir H", "settlement": "Girgaum, Mumbai", "region": "Maharashtra", "country": "India"}}, "email": ""}, {"first": "", "middle": [], "last": "Vaibhav Bagaria", "suffix": "", "affiliation": {"laboratory": "", "institution": "Indrapratsha Apollo Hospitals", "location": {"settlement": "New Delhi"}}, "email": ""}]}, "abstract": [{"text": "India 400004 J o u r n a l P r e -p r o o f", "cite_spans": [], "ref_spans": [], "section": "Abstract"}], "body_text": [{"text": "It is an old saying that 'As one goes too close to the tree, one stands losing the sight of the forest' Today researchers are continually providing newer and valuable insight on COVID19. Sadly, the world is becoming increasingly cluttered with unorganized and unconfirmed data. We believe that it is time to take a pause and look at what we have learned so far and organize it in an orchestrated manner.", "cite_spans": [], "ref_spans": [], "section": "Understanding the COVID19 Conundrum and Decluttering the scientific literature on COVID19"}, {"text": "COVID 19 is not a single disease but a spectrum. Patient condition specific management is key to successful outcome. COVID can be classified into 4 main types based on type of presentation. These may further be sub-classified based on predominant organ affliction (Table 1) .", "cite_spans": [], "ref_spans": [{"start": 264, "end": 273, "text": "(Table 1)", "ref_id": "TABREF0"}], "section": "Understanding the COVID19 Conundrum and Decluttering the scientific literature on COVID19"}, {"text": "A. COVID-IN: COVID infection but no disease: these are the people who have tested positive on a screening test but never reported any major symptoms beyond a lowgrade fever and myalgia. These people from a medical standpoint just warrant close observation in a home quarantine setting. They should be given wearables that monitor their temperature and Oxygen saturation [1] .", "cite_spans": [{"start": 370, "end": 373, "text": "[1]", "ref_id": "BIBREF0"}], "ref_spans": [], "section": "COVID Classification:"}, {"text": "B. COVID -RI: COVID infection resulting in respiratory infection URTI or LRTI. These occur in early stage of disease and persists for longer duration only in elderly or immunocompromised people. In them the disease behaves as typical pneumonia affecting the respiratory system. In these people ensuring that early institution of antivirals (e.g. Remdesivir), broad spectrum antibiotics (e.g., Amoxiclav) to prevent secondary infection, saturations are maintained, aggressive chest physiotherapy and good nursing care are key to successful outcomes. Assisted Ventilation where possible should be the last resort as weaning them away from the ventilators may prove difficult [2] .", "cite_spans": [{"start": 673, "end": 676, "text": "[2]", "ref_id": "BIBREF1"}], "ref_spans": [], "section": "COVID Classification:"}, {"text": "C. COVID -I: COVID infection resulting in Immunological condition. This subset consists of relatively young people with a strong immune system who have responded to COVID infection in an unusually strong and atypical fashion much like an autoimmune disease -Systemic Lupus Erythematosus (SLE). Just like SLE, the manifestation can be varied and organ-specific [3] . The subtypes depending on the predominant organ affliction are described below. Just like any other autoimmune disorder, the focus will be on lowering the inciting agent load by giving antivirals early on along with disease-modifying agents/ biologicals that limit inflammation for e.g., Tocilizumab.", "cite_spans": [{"start": 360, "end": 363, "text": "[3]", "ref_id": "BIBREF2"}], "ref_spans": [], "section": "COVID Classification:"}, {"text": "D. COVID -S: COVID sequalae -No active infection but COVID has resulted in residual damages. These appear between 4 weeks and 3 months of the COVID infection [8] . Depending on the primary subtype, it may affect different organs. ", "cite_spans": [{"start": 158, "end": 161, "text": "[8]", "ref_id": "BIBREF7"}], "ref_spans": [], "section": "COVID Classification:"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review", "authors": [{"first": "D", "middle": ["P"], "last": "Oran", "suffix": ""}, {"first": "E", "middle": ["J"], "last": "Topol", "suffix": ""}], "year": 2020, "venue": "Ann Intern Med", "volume": "173", "issn": "5", "pages": "362--367", "other_ids": {"DOI": ["10.7326/M20-3012.Epub"], "PMID": ["32491919"], "PMCID": ["PMC7281624"]}}, "BIBREF1": {"ref_id": "b1", "title": "An Updated Understanding of the Current Emerging Respiratory Infection: COVID-19", "authors": [{"first": "H", "middle": [], "last": "Yuan", "suffix": ""}, {"first": "X", "middle": [], "last": "Cao", "suffix": ""}, {"first": "Ji", "middle": ["X"], "last": "Du", "suffix": ""}, {"first": "F", "middle": [], "last": "He", "suffix": ""}, {"first": "J", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "X", "middle": [], "last": "Xie", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "Y", "middle": [], "last": "", "suffix": ""}], "year": 2020, "venue": "Biomed Res Int", "volume": "2020", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1155/2020/6870512"], "PMID": ["33134384"], "PMCID": ["PMC7591962"]}}, "BIBREF2": {"ref_id": "b2", "title": "Extra-respiratory manifestations of COVID-19", "authors": [{"first": "C", "middle": ["C"], "last": "Lai", "suffix": ""}, {"first": "W", "middle": ["C"], "last": "Ko", "suffix": ""}, {"first": "P", "middle": ["I"], "last": "Lee", "suffix": ""}, {"first": "S", "middle": ["S"], "last": "Jean", "suffix": ""}, {"first": "P", "middle": ["R"], "last": "Hsueh", "suffix": ""}], "year": 2020, "venue": "Int J Antimicrob Agents", "volume": "56", "issn": "2", "pages": "", "other_ids": {"DOI": ["10.1016/j.ijantimicag.2020.106024.Epub"], "PMID": ["32450197"]}}, "BIBREF3": {"ref_id": "b3", "title": "Is COVID-19 a New Hematologic Disease? Stem Cell Rev Rep", "authors": [{"first": "B", "middle": [], "last": "Debuc", "suffix": ""}, {"first": "D", "middle": ["M"], "last": "Smadja", "suffix": ""}], "year": 2021, "venue": "", "volume": "17", "issn": "", "pages": "4--8", "other_ids": {"DOI": ["10.1007/s12015-020-09987-4"], "PMID": ["32399806"], "PMCID": ["PMC7217340"]}}, "BIBREF4": {"ref_id": "b4", "title": "Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality", "authors": [{"first": "R", "middle": ["O"], "last": "Bonow", "suffix": ""}, {"first": "G", "middle": ["C"], "last": "Fonarow", "suffix": ""}, {"first": "O", "middle": [], "last": "Gara", "suffix": ""}, {"first": "P", "middle": ["T"], "last": "", "suffix": ""}, {"first": "Yancy", "middle": [], "last": "Cw", "suffix": ""}], "year": 2020, "venue": "JAMA Cardiol", "volume": "5", "issn": "7", "pages": "751--753", "other_ids": {"DOI": ["10.1001/jamacardio.2020.1105"], "PMID": ["32219362"]}}, "BIBREF5": {"ref_id": "b5", "title": "The Unfolding Palette of COVID-19Multisystemic Syndrome and its Neurological Manifestations. Brain Behav Immun Health", "authors": [{"first": "F", "middle": ["J"], "last": "Barrantes", "suffix": ""}], "year": 2021, "venue": "", "volume": "14", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/j.bbih.2021.100251"], "PMID": ["33842898"], "PMCID": ["PMC8019247"]}}, "BIBREF6": {"ref_id": "b6", "title": "Severe arterial thrombosis associated with Covid-19 infection", "authors": [{"first": "M", "middle": [], "last": "Kashi", "suffix": ""}, {"first": "A", "middle": [], "last": "Jacquin", "suffix": ""}, {"first": "B", "middle": [], "last": "Dakhil", "suffix": ""}, {"first": "R", "middle": [], "last": "Zaimi", "suffix": ""}, {"first": "E", "middle": [], "last": "Mah\u00e9", "suffix": ""}, {"first": "Tella", "middle": ["E"], "last": "Bagan", "suffix": ""}, {"first": "P", "middle": [], "last": "", "suffix": ""}], "year": 2020, "venue": "Thromb Res", "volume": "192", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/j.thromres.2020.05.025"], "PMID": ["32425264"]}}, "BIBREF7": {"ref_id": "b7", "title": "Long-Term Respiratory and Neurological Sequelae of COVID-19", "authors": [{"first": "F", "middle": [], "last": "Wang", "suffix": ""}, {"first": "R", "middle": ["M"], "last": "Kream", "suffix": ""}, {"first": "G", "middle": ["B"], "last": "Stefano", "suffix": ""}], "year": 2020, "venue": "Med Sci Monit", "volume": "26", "issn": "", "pages": "", "other_ids": {"DOI": ["10.12659/MSM.928996"], "PMID": ["33177481"]}}}, "ref_entries": {"FIGREF0": {"text": "Distribution of two major COVID 19 pattern changes with Age and co morbidities. An intermediary group will have features of both the patterns. Younger patients are more likely to have strong immune response components and older patient predominant respiratory affliction resulting in respiratory failures. J o u r n a l P r e -p r o o f", "latex": null, "type": "figure"}, "TABREF0": {"text": "COVID Classification Diagnosed on US/MRI; Antibiotics; Incision and drainage; Beware of Joint Sepsis Bone Necrosis/ Infarcts Primary and secondary to steroid use; May require Core decompression/ Alendronate Neuro weakness Self-limiting with rapid recovery; Physiotherapy Others (Unclassified) Surgical Site Infections; Conjunctivitis; Dermatological conditions Fig 1: Deciphering various patterns of COVID 19 using a simple flowchart. One must be aware of overlapping/mixed patterns.", "latex": null, "type": "table"}}, "back_matter": [{"text": "Authors declare no conflict of interest pertaining to the manuscript.", "cite_spans": [], "ref_spans": [], "section": "Conflict of Interest Statement"}, {"text": "No financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work", "cite_spans": [], "ref_spans": [], "section": "No external funding"}]}